A Promoter Polymorphism of the Endothelial Nitric Oxide Synthase Gene is Associated With Reduced mRNA and Protein Expression in Failing Human Myocardium

Journal of Cardiac Failure

Volumn 16, Issue 4, 2010, Pages 314-319

  Doshi, Amit A ^a,b   Ziolo, Mark T ^a,b   Wang, Honglan ^a,b   Burke, Emily ^a   Lesinski, Amanda ^a   Binkley, Philip ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

cardiomyopathy; genetics; Nitric oxide; pharmacogenetics

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; ALLELE; ARTICLE; CLINICAL ARTICLE; DNA ISOLATION; DNA POLYMORPHISM; FEMALE; GENE AMPLIFICATION; HEART FAILURE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; CYTOSINE NUCLEOTIDES; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; THYMINE NUCLEOTIDES;

EID: 77949914823     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.12.013     Document Type: Article

References (23)

1. Cook S. Coronary artery disease, nitric oxide and oxidative stress: the "Yin-Yang" effect-a Chinese concept for a worldwide pandemic. Swiss Med Wkly 136 (2006) 103-113
2. Cooke G.E., Doshi A., and Binkley P.F. Endothelial nitric oxide synthase gene: prospects for treatment of heart disease. Pharmacogenomics 8 (2007) 1723-1734
3. Cooke J.P., and Losordo D.W. Nitric oxide and angiogenesis. Circulation 105 (2002) 2133-2135
4. McNamara D.M., Holubkov R., Postava L., Ramani R., Janosko K., Mathier M., et al. Effect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failure. Circulation 107 (2003) 1598-1602
5. Ziolo M.T., Kohr M.J., and Wang H. Nitric oxide signaling and the regulation of myocardial function. J Mol Cell Cardiol 45 (2008) 625-632
6. Stein B., Frank P., Schmitz W., Scholz H., and Thoenes M. Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. J Mol Cell Cardiol 28 (1996) 1631-1639
7. Binkley P.F., Nunziatta E., Liu-Stratton Y., and Cooke G. A polymorphism of the endothelial nitric oxide synthase promoter is associated with an increase in autonomic imbalance in patients with congestive heart failure. Am Heart J 149 (2005) 342-348
8. Cai H., Wilcken D.E., and Wang X.L. The Glu-298->Asp (894G->T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease. J Mol Med 77 (1999) 511-514
9. Hingorani A.D., Liang C.F., Fatibene J., Lyon A., Monteith S., Parsons A., et al. A common variant of the endothelial nitric oxide synthase (Glu298->Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100 (1999) 1515-1520
10. Shimasaki Y., Yasue H., Yoshimura M., Nakayama M., Kugiyama K., Ogawa H., et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 31 (1998) 1506-1510
11. Marroni A.S., Metzger I.F., Souza-Costa D.C., Nagassaki S., Sandrim V.C., Correa R.X., et al. Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide 12 (2005) 177-182
12. Pfaffl M.W. Quantification strategies in real-time PCR. In: Bustin S. (Ed). A-Z of quantitative PCR (2004), International University Line, La Jolla, CA
13. Nakayama M., Yasue H., Yoshimura M., Shimasaki Y., Kugiyama K., Ogawa H., et al. T-786->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99 (1999) 2864-2870
14. Dosenko V.E., Zagoriy V.Y., Haytovich N.V., Gordok O.A., and Moibenko A.A. Allelic polymorphism of endothelial NO-synthase gene and its functional manifestations. Acta Biochim Polon 53 (2006) 299-302
15. Gomma A.H., Elrayess M.A., Knight C.J., Hawe E., Fox K.M., and Humphries S.E. The endothelial nitric oxide synthase (Glu298Asp and -786T>C) gene polymorphisms are associated with coronary in-stent restenosis. Eur Heart J 23 (2002) 1955-1962
16. Rossi G.P., Cesari M., Zanchetta M., Colonna S., Maiolino G., Pedon L., et al. The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study. J Am Coll Cardiol 41 (2003) 930-937
17. Cattaruzza M., Guzik T.J., Slodowski W., Pelvan A., Becker J., Halle M., et al. Shear stress insensitivity of endothelial nitric oxide synthase expression as a genetic risk factor for coronary heart disease. Circ Res 15 (2004) 841-847
18. Fairchild T.A., Fulton D., Fontana J.T., Gratton J.P., McCabe T.J., and Sessa W.C. Acidic hydrolysis as a mechanism for the cleavage of the Glu(298)->Asp variant of human endothelial nitric-oxide synthase. J Biol Chem 276 (2001) 26674-26679
19. Kato N., Sugiyama T., Morita H., Nabika T., Kurihara H., Yamori Y., et al. Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension 33 (1999) 933-936
20. Rossi G.P., Maiolino G., Zanchetta M., Sticchi D., Pedon L., Cesari M., et al. The T(-786)C endothelial nitric oxide synthase genotype predicts cardiovascular mortality in high-risk patients. J Am Coll Cardiol 48 (2006) 1166-1174
21. Raman C.S., Li H., Martasek P., Kral V., Masters B.S., and Poulos T.L. Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell 95 (1998) 939-950
22. Tesauro M., Thompson W.C., Rogliani P., Qi L., Chaudhary P.P., and Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A 97 (2000) 2832-2835
23. Rossi G.P., and Cesari M. Reply. J Am Coll Cardiol 49 (2007) 1226-1227